Agilent Technologies Inc (A) Position Reduced by Sentry Investment Management LLC

Sentry Investment Management LLC lessened its stake in Agilent Technologies Inc (NYSE:A) by 46.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,003 shares of the medical research company’s stock after selling 9,640 shares during the period. Sentry Investment Management LLC’s holdings in Agilent Technologies were worth $776,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of A. OppenheimerFunds Inc. increased its position in Agilent Technologies by 64.0% during the 2nd quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock valued at $472,248,000 after purchasing an additional 2,980,216 shares during the period. American Century Companies Inc. increased its position in Agilent Technologies by 16.9% during the 3rd quarter. American Century Companies Inc. now owns 5,359,933 shares of the medical research company’s stock valued at $378,090,000 after purchasing an additional 774,771 shares during the period. Wells Fargo & Company MN increased its position in Agilent Technologies by 6.6% during the 2nd quarter. Wells Fargo & Company MN now owns 2,984,214 shares of the medical research company’s stock valued at $184,544,000 after purchasing an additional 183,728 shares during the period. Schwab Charles Investment Management Inc. increased its position in Agilent Technologies by 3.9% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,329,409 shares of the medical research company’s stock valued at $82,211,000 after purchasing an additional 49,527 shares during the period. Finally, Morgan Stanley increased its position in Agilent Technologies by 67.6% during the 2nd quarter. Morgan Stanley now owns 1,227,627 shares of the medical research company’s stock valued at $75,917,000 after purchasing an additional 495,160 shares during the period.

A has been the topic of a number of research reports. ValuEngine raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Wednesday, July 25th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research report on Tuesday, August 7th. Morgan Stanley raised their target price on shares of Agilent Technologies from $83.00 to $84.00 and gave the company an “overweight” rating in a research report on Wednesday, August 15th. Deutsche Bank raised their target price on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, August 15th. Finally, Goldman Sachs Group raised shares of Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a research report on Monday, September 17th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $77.44.

NYSE:A opened at $67.27 on Friday. Agilent Technologies Inc has a fifty-two week low of $60.42 and a fifty-two week high of $75.00. The stock has a market capitalization of $21.76 billion, a PE ratio of 28.50, a PEG ratio of 2.13 and a beta of 1.35. The company has a current ratio of 3.62, a quick ratio of 3.00 and a debt-to-equity ratio of 0.39.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, August 14th. The medical research company reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.63 by $0.04. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The business had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period last year, the business earned $0.59 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. As a group, equities research analysts forecast that Agilent Technologies Inc will post 2.71 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 24th. Stockholders of record on Tuesday, October 2nd were issued a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend was Monday, October 1st. Agilent Technologies’s dividend payout ratio is currently 25.42%.

In other news, Director Heidi Fields sold 5,482 shares of the firm’s stock in a transaction dated Tuesday, September 11th. The shares were sold at an average price of $67.73, for a total value of $371,295.86. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Paul N. Clark sold 2,876 shares of the firm’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $68.60, for a total transaction of $197,293.60. The disclosure for this sale can be found here.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.wkrb13.com/2018/11/10/agilent-technologies-inc-a-position-reduced-by-sentry-investment-management-llc.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

See Also: Can individual investors take part in an IPO?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply